Immune Thrombocytopenia (ITP): Current Limitations in Patient Management

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia caused by increased platelet destruction and impaired platelet production. First-line therapies include corticosteroids, intravenous immunoglobulin, and anti-D immunoglobulin. For pati...

Full description

Bibliographic Details
Main Authors: Deirdra R. Terrell, Cindy E. Neunert, Nichola Cooper, Katja M. Heitink-Pollé, Caroline Kruse, Paul Imbach, Thomas Kühne, Waleed Ghanima
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Medicina
Subjects:
immune thrombocytopenia (ITP)
quality of life
treatment
refractory
Online Access:https://www.mdpi.com/1010-660X/56/12/667

Internet

https://www.mdpi.com/1010-660X/56/12/667

Similar Items